Page 7 - Polypid Ltd News Today

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

PolyPid Ltd. (NASDAQ:NASDAQ:PYPD) Q1 2022 Earnings Conference Call May 11, 2022 8:30 AM ET Company Participants Bob Yedid - Investor Relations, LifeSci Advisors Amir Weisberg - Chief...

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

Biotech stocks posted weekly declines yet again in the week ending April 29, taking cues from the weak broader market sentiment. Big pha...

Treace Medical Concepts (NASDAQ:TMCI – Get Rating) and PolyPid (NASDAQ:PYPD – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, dividends, institutional ownership, profitability and earnings. Institutional and Insider Ownership 38.8% of Treace Medical Concepts […]

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

Wall Street analysts expect that PolyPid Ltd. (NASDAQ:PYPD – Get Rating) will announce earnings of ($0.68) per share for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have issued estimates for PolyPid’s earnings. PolyPid reported earnings of ($0.47) per share during the same quarter last year, which indicates a negative year over […]

PolyPid Ltd. (NASDAQ:PYPD – Get Rating) saw a significant increase in short interest in the month of February. As of February 28th, there was short interest totalling 119,900 shares, an increase of 17.1% from the February 13th total of 102,400 shares. Currently, 0.8% of the shares of the stock are sold short. Based on an […]

Brokerages expect PolyPid Ltd. (NASDAQ:PYPD – Get Rating) to announce ($0.68) earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have provided estimates for PolyPid’s earnings. PolyPid reported earnings per share of ($0.47) in the same quarter last year, which suggests a negative year over year growth rate […]

PolyPid Announces Planned CEO Transition Current EVP & CFO, Dikla Czaczkes Akselbrad, Appointed CEO, Effective July 2022 - read this article along with other careers information, tips and advice on BioSpace